Previous 10 | Next 10 |
home / stock / cvs / cvs articles
2024 will mark a pivotal moment for the healthcare industry, particularly in drug pricing negotiations. The forthcoming year will provide the first...
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have hig...
As Christmas Eve approaches, individuals are gearing up for last-minute shopping. While business closings on Christmas Eve are less comm...
The U.S. Supreme Court is set to deliberate on the future of mifepristone, a crucial drug employed in over half of all abortions within the U.S.&nb...
A congressional review of some major pharmacy chains' privacy practices found that none require a warrant before sharing customers' records...
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have hig...
An annual survey reveals the fastest growing brands in the U.S. and includes rankings for fast growth brands amongst different age groups. Likely t...
On CNBC’s "Halftime Report Final Trades," Stephen Weiss of Short Hills Capital Partners said he is staying with U.S. 1 Year Treasur...
CVS Health Corp (NYSE: CVS) announced a new approach called CVS 'CostVantage' that evolves the traditional pharmacy reimbursement mode...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, July 15, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased securities of CVS Health Corporat...
CVS Health to hold second quarter 2024 earnings conference call PR Newswire WOONSOCKET, R.I. , July 8, 2024 /PRNewswire/ -- CVS Health (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, August 7 th , 2024, at 8:00 a.m. ET ...
2024-07-03 08:15:00 ET Some beaten-down stocks have significant upside potential and, therefore, present attractive buying opportunities for investors. However, other companies that are failing to keep pace with the market and are likely to keep struggling for a long time aren't worth inves...